ERBB2 and neoplasm: Tumours classified as luminal A showed significantly higher expression of the signature compared with luminal B (p-value < 2.2e-16; Wilcoxon rank-sum test) and TNBC/HER2 + lesions (p-value = 1.9e-8) (Supplementary Fig. 8d).